Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca Pharma India Ltd. Regulatory Filings 2021

Jul 27, 2021

60656_rns_2021-07-27_b762451b-18e5-4b94-883a-8d33cd1f2eac.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

==> picture [524 x 91] intentionally omitted <==

July 26, 2021

The Manager –Listing BSE Limited

Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

National Stock Exchange of India Ltd. Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

Dear Sir,

Sub: Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018

We are enclosing herewith Certificate dated July 12, 2021 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.

Please take the same on record.

Yours faithfully, For AstraZeneca Pharma India Limited

PRATAP Digitally signed by RUDRA PRATAP RUDRA BHUVANAGIRI BHUVANAGI Date: 2021.07.26 RI 21:40:04 +05'30'

Pratap Rudra

Company Secretary & Legal Counsel

Encl: as above

==> picture [452 x 64] intentionally omitted <==

==> picture [158 x 37] intentionally omitted <==

==> picture [85 x 45] intentionally omitted <==

IRMSPL/ASTRA/06K/JULY2021

July 12, 2021

To,

AstraZeneca Pharma India Limited Block N1, 12[th] Floor Manyata Embassy Business Park Rachenahalli Outer Ring Road Bangalore � 560 045

Kind Attn: Mr. Pratap Rudra - Company Secretary & Compliance Officer

Dear Sir,

Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Sub: Regulations, 2018 - For the period 01.06.2021 to 30.06.2021

This has reference to the Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we hereby confirm that we have complied with the following actions within extended timelines as provided in the SEBI's circular SEBI/HO/MIRSD/DOP/CIR/P/2020/112 dated June 30, 2020 for the purpose of dematerialization:

1) The securities comprised in the certificate(s) Dematerialized, are listed on the stock exchange or exchanges where the earlier issued securities are listed.

2) Mutilated and canceled the certificate of security forwarded by the participants.

3) Substituted the name of the depository as the registered owner in our records.

Thanking You,

Yours faithfully,

For Integrated Registry Management Services Private Limited

S Digitally signed by S VIJAYAGOPAL VIJAYAGOPAL Date: 2021.07.12 17:21:47 +05'30'

S Vijayagopal Vice President

Checked by:

==> picture [63 x 27] intentionally omitted <==

Page:1/1

INTEGRATED REGISTRY MANAGEMENT SERVICES PRIVATE LTD

  • 30, Ramana Residency, 4[th] Cross, Sampige Road, Malleswaram, Bangalore – 560 003. Phone No.: 080 2346 0815 to 818 Fax No .: 080 2346 0819

Fixed Deposits related query Email ID: [email protected] / Shares related query Email ID: [email protected] Regd.Office : 2[nd] Floor,Kences Towers, No.1, Ramakrishna Street, North Usman Road, T. Nagar, Chennai – 600 017 CIN : U74900TN2015PTC101466 ; SEBI Regn No: INR000000544 “Appointment of a nominee for the shares held by you is not an o 1 ption but your right!! Please exercise your right to nominate”